Abstract
New Zealand (NZ) is one of few countries to shift from PCV13 to PCV10. The number of serotype 19A cases in young children and the proportions of isolates that are penicillin-resistant have been steadily increasing since. It is time for NZ to reconsider its choice of pneumococcal vaccine.
Author supplied keywords
Cite
CITATION STYLE
APA
Anglemyer, A., Mcneill, A., Dubray, K., Sonder, G. J. B., & Walls, T. (2022). Invasive Pneumococcal Disease: Concerning Trends in Serotype 19A Notifications in New Zealand. Clinical Infectious Diseases, 74(10), 1859–1861. https://doi.org/10.1093/cid/ciab766
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free